Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) shares in Thousands, $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Nov. 30, 2023 |
Nov. 30, 2022 |
Nov. 30, 2023 |
Nov. 30, 2022 |
|
| Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) | ||||
| Revenue from contracts with customers | $ 26 | $ 25 | $ 108 | $ 160 |
| Expenses : | ||||
| Research and development (Note 13) | 1,833 | 4,582 | 8,361 | 15,133 |
| General and administrative (Note 14) | 2,458 | 3,183 | 7,767 | 18,230 |
| Depreciation and amortization (Notes 6 and 7) | 131 | 134 | 400 | 411 |
| Total expenses | 4,422 | 7,899 | 16,528 | 33,774 |
| Other (income) loss : | ||||
| Gain on disposition of assets (Note 6) | 0 | (6,704) | 0 | (6,704) |
| Interest and other financial expenses | 42 | 54 | 140 | 139 |
| Interest income | (166) | (13) | (484) | (36) |
| Foreign exchange gain | (28) | (198) | (81) | (289) |
| Total other (income) loss | (152) | (6,861) | (425) | (6,890) |
| Net loss | (4,244) | (1,013) | (15,995) | (26,724) |
| Foreign currency translation adjustment | (83) | (440) | 21 | (857) |
| Comprehensive loss | $ (4,327) | $ (1,453) | $ (15,974) | $ (27,581) |
| Net loss per share | ||||
| Basic and diluted | $ (0.09) | $ (0.02) | $ (0.34) | $ (0.56) |
| Weighted average common shares outstanding | ||||
| Basic and diluted | 47,523,817 | 47,416,340 | 47,520,356 | 47,405,801 |